Oppenheimer analysts downgraded Pliant Therapeutics stock from Outperform to Perform, following a significant development ...

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia’s declining revenues. See why I ...

SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR) announced today that its drug candidate, rezpegaldesleukin, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ...

Parex Resources expanded its joint venture with Ecopetrol. Learn more about PARXF stock here and why it is rated as Strong ...

Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –– Capital raising was strongly supported by domestic and ...

Nigel Farage has called for an end to “death taxes” in his address to British farmers ahead of a planned rally in Westminster. On stage at a gathering of the group Farmers to Action, the Reform UK ...

Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D ...

The Balance Sheet Page of Kotak Mahindra Bank Ltd. presents the key ratios, its comparison with the sector peers and 5 years of Balance Sheet.